Journal of Genetic Counseling

, Volume 16, Issue 3, pp 313–324 | Cite as

Sharing GJB2/GJB6 Genetic Test Information with Family Members

  • Terri Blase
  • Ariadna Martinez
  • Wayne W. Grody
  • Lisa Schimmenti
  • Christina G. S. Palmer
Original Research

Although GJB2/GJB6 genetic testing for non-syndromic hearing loss is available, there is no information regarding sharing of test results with family members. A qualitative study was conducted to elucidate if, how, and why parents of a child with hearing loss share GJB2/GJB6 test results with relatives. Parents whose child had testing (n = 7 positive, n = 4 negative, n = 1 inconclusive results) participated in a semi-structured interview and responses were analyzed using qualitative methods. All participants shared the test result with at least one relative, but selective non-disclosure also was observed. Reasons for, and reactions to, sharing were diverse and differed as a function of test result. In comparing the results from this study to published literature, similarities and differences were identified with regards to disclosure of genetic test results for hearing loss versus other conditions. Differences suggest that hearing loss may have unique attributes that influence responses to genetic test information. Further research is needed to replicate these findings.

KEY WORDS:

genetic testing connexin 26 Cx26 GJB2 disclosure family hearing loss deafness genetic counseling 

Notes

ACKNOWLEDGMENTS

This research was supported by National Institute on Deafness and Other Communication Disorders (NIDCD) Grant DC005663 and California State University Northridge Thesis Support Program (2004–2005). The authors are grateful to the participating families who generously gave their time and support to allow performance of this study and to two anonymous reviewers who provided constructive criticism on an earlier version of this manuscript.

REFERENCES

  1. Abe, S., Usami, S., Shinkawa, H., Kelley, P. M., & Kimberling, W. J. (2000). Prevalent connexin 26 gene (GJB2) mutations in Japanese. J Med Genet, 37, 41–43.PubMedCrossRefGoogle Scholar
  2. Anderlik, M. R., & Lisko, E. A. (2000). Medicolegal and ethical issues in genetic cancer syndromes. Semin Surg Oncol, 18, 339–346.PubMedCrossRefGoogle Scholar
  3. Arnos, K. S., Israel, J., & Cunningham, M. (1991). Genetic counseling of the deaf. Medical and cultural considerations. Ann NY Acad Sci, 630, 212–222.PubMedCrossRefGoogle Scholar
  4. Azaiez, H., Chamberlin, G. P., Fischer, S. M., Welp, C. L., Prasad, S., Taggart, R. R., et al. (2004). GJB2: The spectrum of deafness-causing allele variants and their phenotype. Human Mutation, 24, 305–311.PubMedCrossRefGoogle Scholar
  5. Billings, K. R., & Kenna, M. A. (1999). Causes of pediatric sensorineural hearing loss: Yesterday and today. Arch Otolaryngol, 125, 517–521.Google Scholar
  6. Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2003). Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A, 116, 11–19.PubMedCrossRefGoogle Scholar
  7. Cryns, K., Orzan, E., Murgia, A., Huygen, P. L. M., Moreno, F., del Castillo, I., et al. (2004). A genotype-phenotype correlation for GJB2 (connexin 26) deafness. J Med Genet, 41, 147–154.PubMedCrossRefGoogle Scholar
  8. del Castillo, I., Villamar, M., Moreno-Pelayo, M. A., del Castillo, F. J., Alvarez, A., Telleria, D., et al. (2002). A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. New Engl J Med, 346, 243–249.PubMedCrossRefGoogle Scholar
  9. Denoyelle, F., Lina-Granade, G., Plauchu, H., Bruzzone, R., Chaib, H., Levi-Acobas, F., et al. (1998). Connexin 26 gene linked to a dominant deafness. Nature, 393, 319–320.PubMedCrossRefGoogle Scholar
  10. Denoyelle, F., Marlin, S., Weil, D., Moatti, L., Chauvin, P., Garabedian, E. N., et al. (1999). Clinical features of the prevalent form of childhood deafness, DFNB1, due to a connexin-26 gene defect: Implications for genetic counselling. Lancet, 353, 1298–1303.PubMedCrossRefGoogle Scholar
  11. Estivill, X., Fortina, P., Surrey, S., Rabionet, R., Melchionda, S., D’Agruma, L., et al. (1998). Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet, 351, 394–398.PubMedCrossRefGoogle Scholar
  12. Flick, U. (1998). An introduction to qualitative research. London: Sage.Google Scholar
  13. Gorlin, R. J., Toriello, H. V., & Cohen Jr., M. M. (1995). Hereditary hearing loss and its syndromes. New York: Oxford University Press, Inc.Google Scholar
  14. Green, G. E., Scott, D. A., McDonald, J. M., Woodworth, G. G., Sheffield, V. C., & Smith, R. J. (1999). Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA, 281, 2211–2216.PubMedCrossRefGoogle Scholar
  15. Henneman, L., Kooij, L., Bouman, K., & ten Kate, L. P. (2002). Personal experiences of cystic fibrosis (CF) carrier couples prospectively identified in CF families. Am J Med Genet, 110, 324–331.PubMedCrossRefGoogle Scholar
  16. Hone, S. W., & Smith, R. J. H. (2002). Medical evaluation of pediatric hearing loss: Laboratory, radiographic, and genetic testing. Otolaryng Clin N Am, 35, 751–764.CrossRefGoogle Scholar
  17. Jacobs, L. M. (1989). A deaf adult speaks out. Washington, D.C.: Gallaudet University.Google Scholar
  18. Kenna, M. A., Wu, B. L., Cotanche, D. A., Korf, B. R., & Rehm, H. L. (2001). Connexin 26 studies in patients with sensorineural hearing loss. Arch Otolaryngol Head & Neck Surgery, 127, 1037–1042.Google Scholar
  19. Kenneson, A., Van Naarden Braun, K., & Boyle, C. (2002). GJB2 (connexin 26) variants and non-syndromic sensorineural hearing loss: A huge review. Genet Med, 4, 258–274.PubMedGoogle Scholar
  20. Marlin, S., Garabedian, E. N., Roger, G., Moatti, L., Matha, N., Lewin, P., et al. (2001). Connexin 26 gene mutations in congenitally deaf children: Pitfalls for genetic counseling. Arch Otolaryngol Head Neck Surg, 127, 927–933.PubMedGoogle Scholar
  21. McGivern, B., Everett, J., Yager, G. G., Baumiller, R. C., Hafertepen, A., & Saal, H. M. (2004). Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med, 6, 503–509.PubMedGoogle Scholar
  22. Mesters, I., Ausems, M., Eichhorn, S., & Vasen, H. (2005). Informing one’s family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): A retrospective exploratory study. Fam Cancer, 4, 163–167.PubMedCrossRefGoogle Scholar
  23. Morell, R. J., Kim, H. J., Hood, L. J., Goforth, L., Friderici, K., Fisher, R., et al. (1998). Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med, 339, 1500–1505.PubMedCrossRefGoogle Scholar
  24. Morton, N. E. (1991). Genetic epidemiology of hearing impairment. Ann NY Acad Sci, 630, 16–31.PubMedCrossRefGoogle Scholar
  25. Nance, W. E. (2003). The genetics of deafness. Ment Retard Dev Disabil Res Rev, 9, 109–119.PubMedCrossRefGoogle Scholar
  26. Ormond, K. E., Mills, P. L., Lester, L. A., & Ross, L. F. (2003). Effect of family history on disclosure patterns of cystic fibrosis carrier status. Am J Med Genet, 119C, 70–77.CrossRefPubMedGoogle Scholar
  27. Pallares-Ruiz, N., Blanchet, P., Mondain, M., Claustres, M., & Roux, A.-F. (2002). A large deletion including most of GJB6 in recessive non syndromic deafness: A digenic effect? European J Hum Genet, 10, 72–76.CrossRefGoogle Scholar
  28. Palmer, C. G. S., Martinez, A., Fox, M., Crandall, B., Shapiro, N., Telatar, M., et al. (2003). Genetic testing and the early hearing detection and intervention process. Volta Rev, 103, 371–390.Google Scholar
  29. Pandya, A., Arnos, K. S., Xia, X. J., Welch, K. O., Blanton, S. H., Friedman, T. B., et al. (2003). Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands. Genet Med, 5, 295–303.PubMedGoogle Scholar
  30. Peterson, S. K., Watts, B. G., Koehly, L. M., Vernon, S. W., Baile, W. F., Kohlmann, W. K., et al. (2003). How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet, 119C, 78–86.CrossRefPubMedGoogle Scholar
  31. Schimmenti, L. A., Martinez, A., Fox, M., Crandall, B., Shapiro, N., Telatar, M., et al. (2004). Genetic testing as part of the Early Hearing Detection and Intervention (EHDI) process. Genet Med, 6, 521–525.PubMedCrossRefGoogle Scholar
  32. Smith, K., Zick, C. D., Mayer, R. N., & Botkin, J. R. (2002). Voluntary disclosure of BRCA1 mutation test results. Genet Test, 6, 89–92.PubMedCrossRefGoogle Scholar
  33. Smith, R. (2001). Mutation screening for deafness: More than simply another diagnostic test. Arch Otolaryngol, 127, 941–942.Google Scholar
  34. Smith, S. (1991). Recurrence risks. Ann NY Acad Sci, 630, 203–211.PubMedCrossRefGoogle Scholar
  35. Sorenson, J. R., Jennings-Grant, T., & Newman, J. (2003). Communication about carrier testing within hemophilia A families. Am J Med Genet C, 119, 3–10.CrossRefGoogle Scholar
  36. Wagner Costalas, J., Itzen, M., Malick, J., Babb, J. S., Bove, B., Godwin, A. K., et al. (2003). Communication of BRCA1 and BRCA2 results to at-risk relatives: A cancer risk assessment program’s experience. Am J Med Genet C, 119, 11–18.CrossRefGoogle Scholar
  37. Williams, J. K., & Schutte, D. L. (1997). Benefits and burdens of genetic carrier identification. Western J Nurs Res, 19, 71–81.CrossRefGoogle Scholar
  38. Zelante, L., Gasparini, P., Estivill, X., Melchionda, S., D’Agruma, L., Govea, N., et al. (1997). Connexin26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol Genet, 6, 1605–1609.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Terri Blase
    • 1
    • 5
  • Ariadna Martinez
    • 2
  • Wayne W. Grody
    • 3
  • Lisa Schimmenti
    • 4
  • Christina G. S. Palmer
    • 2
    • 3
    • 6
  1. 1.Department of BiologyCalifornia State University NorthridgeNorthridgeUSA
  2. 2.Department of Psychiatry & Biobehavioral SciencesUniversity of California Los AngelesLos AngelesUSA
  3. 3.Department of Human GeneticsUniversity of California Los AngelesLos AngelesUSA
  4. 4.Departments of Pediatrics and Ophthalmology, Institute of Human GeneticsUniversity of MinnesotaMinneapolisUSA
  5. 5.Advocate Christ Medical CenterOak LawnUSA
  6. 6.UCLA Semel InstituteLos AngelesUSA

Personalised recommendations